|
US6673779B2
(en)
*
|
1996-03-27 |
2004-01-06 |
Inspire Pharmaceuticals, Inc. |
Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues
|
|
US6319908B1
(en)
|
1996-07-03 |
2001-11-20 |
Inspire Pharmaceuticals, Inc. |
Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
|
|
US5763447C1
(en)
|
1996-07-23 |
2002-05-07 |
Inspire Pharmaceuticals |
Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
|
|
CN1262556C
(zh)
|
1997-02-06 |
2006-07-05 |
印斯拜尔药品股份有限公司 |
特定的二核苷酸和它们作为粘膜纤毛清除和纤毛颤动频率调节剂的应用
|
|
US6596725B2
(en)
*
|
1997-02-10 |
2003-07-22 |
Inspire Pharmaceuticals, Inc. |
Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema
|
|
US6818629B2
(en)
*
|
1997-02-10 |
2004-11-16 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
|
|
US7223744B2
(en)
|
1997-02-10 |
2007-05-29 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
|
|
US7078391B2
(en)
|
1997-02-10 |
2006-07-18 |
Inspire Pharmaceuticals, Inc. |
Method of treating edematous retinal disorders
|
|
US6548658B2
(en)
*
|
1997-07-25 |
2003-04-15 |
Inspire Pharmaceuticals, Inc. |
Di-(uridine 5′)-tetraphosphate and salts thereof
|
|
WO1999005155A2
(en)
*
|
1997-07-25 |
1999-02-04 |
Inspire Pharmaceuticals, Inc. |
Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
|
|
US6462028B2
(en)
|
1997-07-25 |
2002-10-08 |
Inspire Pharmaceuticals, Inc. |
Method of promoting cervical and vaginal secretions
|
|
TW593331B
(en)
|
1997-07-25 |
2004-06-21 |
Inspire Pharmaceuticals Inc |
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
|
|
US6872710B2
(en)
|
1997-07-25 |
2005-03-29 |
Inspire Pharmaceuticals, Inc. |
Di(uridine 5′)-tetraphosphate and salts thereof
|
|
EP1011688B1
(en)
*
|
1997-08-29 |
2005-02-02 |
The University of North Carolina at Chapel Hill |
Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
|
|
JP4633927B2
(ja)
*
|
1998-05-22 |
2011-02-16 |
インスパイアー ファーマシューティカルズ，インコーポレイティド |
治療用ジヌクレオチドおよび誘導体
|
|
CA2355227A1
(en)
*
|
1998-12-23 |
2000-07-06 |
Richard C. Boucher, Jr. |
Targeted gene transfer using g protein coupled receptors
|
|
DE60015734D1
(de)
|
1999-02-26 |
2004-12-16 |
Inspire Pharmaceuticals Durham |
Verwendung von dinukleotidtriphosphaten, cytidindiphosphaten und adenindiphosphaten zur herstellung einer pharmazeutischen zubereitung zur förderung der schleimauthydratation
|
|
ATE255123T1
(de)
*
|
1999-06-30 |
2003-12-15 |
Yamasa Corp |
Dinucleotid-kristalle
|
|
AU6551800A
(en)
*
|
1999-08-17 |
2001-03-13 |
Adani, Alexander |
Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptasesand viruses
|
|
JP2003524636A
(ja)
*
|
1999-12-22 |
2003-08-19 |
インスパイアー ファーマシューティカルズ，インコーポレイティド |
プリン性受容体アゴニストによる胃腸管の処置方法
|
|
RU2161982C1
(ru)
*
|
2000-01-20 |
2001-01-20 |
Общество с ограниченной ответственностью "Клиника Института биорегуляции и геронтологии" |
Тетрапептид, стимулирующий функцию сетчатой оболочки глаза, фармакологическое средство на его основе и способ его применения
|
|
US6864243B1
(en)
|
2000-05-12 |
2005-03-08 |
Inspire Pharmaceuticals, Inc. |
Method for treating retinal degeneration with purinergic receptor agonists
|
|
AU2001260643B9
(en)
|
2000-05-30 |
2006-10-19 |
Merck Sharp & Dohme Corp. |
Ectocornea extension promoters
|
|
US6867199B2
(en)
|
2000-08-21 |
2005-03-15 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapeutic use
|
|
US7115585B2
(en)
*
|
2000-08-21 |
2006-10-03 |
Inspire Pharmaceuticals, Inc. |
Compositions for treating epithelial and retinal tissue diseases
|
|
US6555675B2
(en)
*
|
2000-08-21 |
2003-04-29 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
|
|
US7132408B2
(en)
*
|
2000-08-21 |
2006-11-07 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
US7452870B2
(en)
*
|
2000-08-21 |
2008-11-18 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with P2Y12 receptor antagonist compound
|
|
US7018985B1
(en)
|
2000-08-21 |
2006-03-28 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
WO2002048165A2
(en)
*
|
2000-12-15 |
2002-06-20 |
Pharmasset Ltd. |
Antiviral agents for treatment of flaviviridae infections
|
|
US20040122223A1
(en)
*
|
2001-02-07 |
2004-06-24 |
Davis Jeremy Martin |
Non-natural nucleotides and dinucleotides
|
|
JP2005508297A
(ja)
|
2001-06-25 |
2005-03-31 |
インスパイアー ファーマシューティカルズ，インコーポレイティド |
Ｐ２ｙプリン受容体作用物質による関節潤滑
|
|
WO2003011885A1
(en)
*
|
2001-07-25 |
2003-02-13 |
Celltech R & D Limited |
Non-natural carbon-linked nucleotides and dinucleotides
|
|
WO2003030892A1
(en)
*
|
2001-10-11 |
2003-04-17 |
Alcon, Inc. |
Methods for treating dry eye
|
|
JP2005532254A
(ja)
|
2001-11-06 |
2005-10-27 |
インスパイアー ファーマシューティカルズ，インコーポレイティド |
炎症性疾患を治療又は予防する方法
|
|
US7084128B2
(en)
*
|
2002-01-18 |
2006-08-01 |
Inspire Pharmaceuticals, Inc. |
Method for reducing intraocular pressure
|
|
JP2006505585A
(ja)
*
|
2002-10-18 |
2006-02-16 |
モリケム メディシンズ， インコーポレイテッド |
ランチビオティクスで眼乾燥症を処置する方法
|
|
US6984628B2
(en)
*
|
2003-07-15 |
2006-01-10 |
Allergan, Inc. |
Ophthalmic compositions comprising trefoil factor family peptides
|
|
EP1753445A4
(en)
*
|
2004-05-06 |
2009-05-20 |
Molichem Medicines Inc |
TREATMENT OF EYE DISEASES AND EYE TREATMENTS WITH LANTIBIOTIC COMPOSITIONS
|
|
WO2005107787A1
(en)
*
|
2004-05-06 |
2005-11-17 |
Molichem Medicines, Inc. |
Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
|
|
GB0417886D0
(en)
*
|
2004-08-11 |
2004-09-15 |
Univ Cardiff |
Method and means for enhanced pulmonary delivery
|
|
GB0502250D0
(en)
*
|
2005-02-03 |
2005-03-09 |
Ic Vec Ltd |
Use
|
|
US7368439B2
(en)
*
|
2005-06-15 |
2008-05-06 |
Bar - Ilan University |
Dinucleoside poly(borano)phosphate derivatives and uses thereof
|
|
US7851456B2
(en)
*
|
2005-06-29 |
2010-12-14 |
Inspire Pharmaceuticals, Inc. |
P2Y6 receptor agonists for treating lung diseases
|
|
EP2036567A3
(en)
|
2005-12-06 |
2009-12-09 |
P2-Science APS |
Modulation of the P2Y2 receptor pathway
|
|
US20070249556A1
(en)
*
|
2006-04-21 |
2007-10-25 |
Brubaker Kurt E |
Method of treating inflammation
|
|
JP5193040B2
(ja)
*
|
2006-07-26 |
2013-05-08 |
ヤマサ醤油株式会社 |
ジ（ピリミジンヌクレオシド５’−）ポリホスフェートの製造法
|
|
US8304529B2
(en)
*
|
2006-07-28 |
2012-11-06 |
Life Technologies Corporation |
Dinucleotide MRNA cap analogs
|
|
US8551534B2
(en)
|
2007-10-10 |
2013-10-08 |
Parion Sciences, Inc. |
Inhaled hypertonic saline delivered by a heated nasal cannula
|
|
US8168597B2
(en)
*
|
2008-10-22 |
2012-05-01 |
Inspire Pharmaceuticals, Inc. |
Method for treating cystic fibrosis
|
|
EP2376518A4
(en)
|
2008-12-18 |
2013-12-04 |
Avaris Ab |
COMPLEX AND METHOD FOR AMPLIFYING NUCLEAR RELEASE
|
|
US9011909B2
(en)
|
2010-09-03 |
2015-04-21 |
Wisconsin Pharmacal Company, Llc |
Prebiotic suppositories
|
|
CN106729718A
(zh)
*
|
2010-09-10 |
2017-05-31 |
参天制药株式会社 |
以组合p2y2受体激动剂和透明质酸或其盐为特征的干眼症治疗剂
|
|
US8778383B2
(en)
|
2011-06-07 |
2014-07-15 |
Parion Sciences, Inc. |
Methods of treatment
|
|
US8945605B2
(en)
|
2011-06-07 |
2015-02-03 |
Parion Sciences, Inc. |
Aerosol delivery systems, compositions and methods
|
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
|
KR101536885B1
(ko)
|
2012-03-26 |
2015-07-14 |
산텐 세이야꾸 가부시키가이샤 |
디쿠아포솔 함유 점안액
|
|
MX2014014648A
(es)
|
2012-05-29 |
2015-09-04 |
Parion Sciences Inc |
Aminoamidas tipo dendrimero que poseen actividad bloqueadora del canal de sodio para el tratamiento de ojo reseco y otras enfermedades mucosas.
|
|
ES2674665T3
(es)
|
2012-12-17 |
2018-07-03 |
Parion Sciences, Inc. |
Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
|
|
SG10201708931XA
(en)
|
2012-12-17 |
2017-12-28 |
Parion Sciences Inc |
Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
|
|
RU2018138195A
(ru)
|
2012-12-17 |
2018-12-18 |
Пэрион Сайенсиз, Инк. |
Соединения 3,5-диамино-6-хлор-n-(n-(4- фенилбутил)карбамимидоил)пиразин-2-карбоксамида
|
|
CN106715454B
(zh)
|
2014-07-24 |
2020-06-16 |
格雷斯公司 |
烟酰胺核苷的结晶形式
|
|
KR102629310B1
(ko)
|
2015-03-09 |
2024-01-24 |
더블유.알. 그레이스 앤드 캄파니-콘. |
니코틴아미드 리보사이드의 결정 형태
|
|
US20180125876A1
(en)
*
|
2015-05-20 |
2018-05-10 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages
|
|
EP3727400A4
(en)
|
2017-12-22 |
2021-10-20 |
Elysium Health, Inc. |
CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE
|
|
EP4157288A2
(en)
|
2020-06-02 |
2023-04-05 |
Institut Gustave-Roussy |
Modulators of purinergic receptors and related immune checkpoint for treating acute respiratory distress syndrom
|
|
EP3919062A1
(en)
|
2020-06-02 |
2021-12-08 |
Institut Gustave-Roussy |
Modulators of purinergic receptors and related immune checkpoint for treating acute respiratory distress syndrom
|